MedTrace Logo

Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection

NCT04904419 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2023-04-18

No results posted yet for this study

Summary

We explores the accuracy and sensitivity of rapid intraoperative detection of IDH, TERT, BRAF indicators through a prospective clinical multi-center study. This part includes a total of 300 fresh tissue samples, paired blood samples, relevant clinical information and follow-up information from 300 patients with different grades of adult glioma. By comparing with the postoperative sequencing results, the specificity and sensitivity of intraoperative IDH and TERT rapid detection results are clear.

Conditions

  • Glioma, Malignant

Interventions

DIAGNOSTIC_TEST

Intraoperative Rapid Detection mutation of IDH, TERT and BRAF v600e

Intraoperative Rapid Detection mutation of IDH, TERT and BRAF v600e

Sponsors & Collaborators

  • Jinsong Wu

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904419 on ClinicalTrials.gov